TPT-004, a TPH inhibitor, exhibits superior pharmacokinetic and pharmacodynamic properties, and demonstrates efficacy in preclinical models for attenuating peripheral serotonin [1] and impeding colorectal tumor growth.
Target:
Others|||Hydroxylase
* VAT and and shipping costs not included. Errors and price changes excepted
